Literature DB >> 4038122

Hemifacial spasm treated with botulinum A toxin injection.

P J Savino, R C Sergott, T M Bosley, N J Schatz.   

Abstract

Fifteen patients with hemifacial spasm were treated with botulinum A toxin injections. All patients experienced relief from spasm, with the effect lasting an average of 12.2 weeks. Complications were tearing in four patients, inability to close the involved eye in three patients, corneal exposure in one patient, and ectropion in one patient. All complications were transient and deemed minor by the patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038122     DOI: 10.1001/archopht.1985.01050090057031

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].

Authors:  J Winterhoff; R Laskawi
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

2.  Blepharospasm and Hemifacial Spasm.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.598

Review 3.  Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin.

Authors:  S P Kraft; A E Lang
Journal:  CMAJ       Date:  1988-11-01       Impact factor: 8.262

4.  Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years.

Authors:  J A Mauriello; J Aljian
Journal:  Br J Ophthalmol       Date:  1991-12       Impact factor: 4.638

5.  Botulinum toxin treatment in patients with hemifacial spasm.

Authors:  R Laskawi; M Ellies; C Drobik; A Bätz
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

6.  Hemifacial Spasm.

Authors:  Lawrence W. Kemp; Stephen G. Reich
Journal:  Curr Treat Options Neurol       Date:  2004-05       Impact factor: 3.598

7.  Botulinum toxin for the treatment of hyperfunctional lines of the forehead.

Authors:  Sathigrama Malegowda Sunil; B Ganesh Babu; Soma Deepthi; Anusha Channabasappa Veerabhadrappa; Suneel V Vadavadagi; Prashant Punde
Journal:  J Int Soc Prev Community Dent       Date:  2015 Jul-Aug

Review 8.  History of Botulinum Toxin Treatment in Movement Disorders.

Authors:  Bahman Jabbari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-11-28

Review 9.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.